2,4-Thiazolidinedione Treatment Improves the Innate Immune Response in Dairy Goats with Induced Subclinical Mastitis

Mastitis is a major disease in dairy cows resulting in significant economic losses. In vitro works suggest that ruminants peroxisome proliferator-activated receptor gamma (PPARγ) can aid in improving the response to mastitis and can control milk fat synthesis. The objectives of the present experimen...

Full description

Saved in:
Bibliographic Details
Main Authors: Fernanda Rosa, Johan S. Osorio, Erminio Trevisi, Francisco Yanqui-Rivera, Charles T. Estill, Massimo Bionaz
Format: Article
Language:English
Published: Wiley 2017-01-01
Series:PPAR Research
Online Access:http://dx.doi.org/10.1155/2017/7097450
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832561802556211200
author Fernanda Rosa
Johan S. Osorio
Erminio Trevisi
Francisco Yanqui-Rivera
Charles T. Estill
Massimo Bionaz
author_facet Fernanda Rosa
Johan S. Osorio
Erminio Trevisi
Francisco Yanqui-Rivera
Charles T. Estill
Massimo Bionaz
author_sort Fernanda Rosa
collection DOAJ
description Mastitis is a major disease in dairy cows resulting in significant economic losses. In vitro works suggest that ruminants peroxisome proliferator-activated receptor gamma (PPARγ) can aid in improving the response to mastitis and can control milk fat synthesis. The objectives of the present experiment were to test if treatment with the putative PPARγ agonist 2,4-thiazolidinedione (TZD) improves (1) the response to subclinical mastitis and (2) milk fat production. Lactating goats received daily injections of 8 mg/kg BW of TZD or saline for 3 weeks. After one week of TZD injection, half of the goats in each group received intramammary infusion of Strep. uberis or saline in both halves for a total of 4 groups (n=6/group). TZD treatment did not affect milk fat but had positive effect on milk somatic cells count, blood nonesterified fatty acids, inflammatory markers, and liver function. TZD significantly increased myeloperoxidase but did not affect leukocytes phagocytosis or insulin. TZD increased adipocytes size and had minor effect on expression of PPARγ target genes in mammary epithelial cells but not in adipose tissue. Overall, TZD ameliorated the response to intramammary infection but the effect on milk fat synthesis and expression of related transcripts was less than expected.
format Article
id doaj-art-d31510ff04ef4770b5e15b23ffb205a9
institution Kabale University
issn 1687-4757
1687-4765
language English
publishDate 2017-01-01
publisher Wiley
record_format Article
series PPAR Research
spelling doaj-art-d31510ff04ef4770b5e15b23ffb205a92025-02-03T01:24:15ZengWileyPPAR Research1687-47571687-47652017-01-01201710.1155/2017/709745070974502,4-Thiazolidinedione Treatment Improves the Innate Immune Response in Dairy Goats with Induced Subclinical MastitisFernanda Rosa0Johan S. Osorio1Erminio Trevisi2Francisco Yanqui-Rivera3Charles T. Estill4Massimo Bionaz5Department of Animal and Rangeland Sciences, Oregon State University, Corvallis, OR 97331, USADepartment of Animal and Rangeland Sciences, Oregon State University, Corvallis, OR 97331, USAIstituto di Zootecnica, Facoltà di Scienze Agrarie, Alimentari e Ambientali, Università Cattolica del Sacro Cuore, 29122 Piacenza, ItalyDepartment of Animal and Rangeland Sciences, Oregon State University, Corvallis, OR 97331, USADepartment of Animal and Rangeland Sciences, Oregon State University, Corvallis, OR 97331, USADepartment of Animal and Rangeland Sciences, Oregon State University, Corvallis, OR 97331, USAMastitis is a major disease in dairy cows resulting in significant economic losses. In vitro works suggest that ruminants peroxisome proliferator-activated receptor gamma (PPARγ) can aid in improving the response to mastitis and can control milk fat synthesis. The objectives of the present experiment were to test if treatment with the putative PPARγ agonist 2,4-thiazolidinedione (TZD) improves (1) the response to subclinical mastitis and (2) milk fat production. Lactating goats received daily injections of 8 mg/kg BW of TZD or saline for 3 weeks. After one week of TZD injection, half of the goats in each group received intramammary infusion of Strep. uberis or saline in both halves for a total of 4 groups (n=6/group). TZD treatment did not affect milk fat but had positive effect on milk somatic cells count, blood nonesterified fatty acids, inflammatory markers, and liver function. TZD significantly increased myeloperoxidase but did not affect leukocytes phagocytosis or insulin. TZD increased adipocytes size and had minor effect on expression of PPARγ target genes in mammary epithelial cells but not in adipose tissue. Overall, TZD ameliorated the response to intramammary infection but the effect on milk fat synthesis and expression of related transcripts was less than expected.http://dx.doi.org/10.1155/2017/7097450
spellingShingle Fernanda Rosa
Johan S. Osorio
Erminio Trevisi
Francisco Yanqui-Rivera
Charles T. Estill
Massimo Bionaz
2,4-Thiazolidinedione Treatment Improves the Innate Immune Response in Dairy Goats with Induced Subclinical Mastitis
PPAR Research
title 2,4-Thiazolidinedione Treatment Improves the Innate Immune Response in Dairy Goats with Induced Subclinical Mastitis
title_full 2,4-Thiazolidinedione Treatment Improves the Innate Immune Response in Dairy Goats with Induced Subclinical Mastitis
title_fullStr 2,4-Thiazolidinedione Treatment Improves the Innate Immune Response in Dairy Goats with Induced Subclinical Mastitis
title_full_unstemmed 2,4-Thiazolidinedione Treatment Improves the Innate Immune Response in Dairy Goats with Induced Subclinical Mastitis
title_short 2,4-Thiazolidinedione Treatment Improves the Innate Immune Response in Dairy Goats with Induced Subclinical Mastitis
title_sort 2 4 thiazolidinedione treatment improves the innate immune response in dairy goats with induced subclinical mastitis
url http://dx.doi.org/10.1155/2017/7097450
work_keys_str_mv AT fernandarosa 24thiazolidinedionetreatmentimprovestheinnateimmuneresponseindairygoatswithinducedsubclinicalmastitis
AT johansosorio 24thiazolidinedionetreatmentimprovestheinnateimmuneresponseindairygoatswithinducedsubclinicalmastitis
AT erminiotrevisi 24thiazolidinedionetreatmentimprovestheinnateimmuneresponseindairygoatswithinducedsubclinicalmastitis
AT franciscoyanquirivera 24thiazolidinedionetreatmentimprovestheinnateimmuneresponseindairygoatswithinducedsubclinicalmastitis
AT charlestestill 24thiazolidinedionetreatmentimprovestheinnateimmuneresponseindairygoatswithinducedsubclinicalmastitis
AT massimobionaz 24thiazolidinedionetreatmentimprovestheinnateimmuneresponseindairygoatswithinducedsubclinicalmastitis